Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8<sup>+</sup> T cell infiltration and functional transition

Anze Yu(Sun Yat-sen University), Junhang Luo(Sun Yat-sen University)
Journal for ImmunoTherapy of Cancer
October 1, 2023
Cited by 22


Related Papers